loading
개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측 주식 분할
전일 마감가:
$1.08
열려 있는:
$1.07
하루 거래량:
12,606
Relative Volume:
0.05
시가총액:
$12.46M
수익:
$996.00K
순이익/손실:
$-6.09M
주가수익비율:
-2.0377
EPS:
-0.53
순현금흐름:
$-9.76M
1주 성능:
-6.09%
1개월 성능:
+25.58%
6개월 성능:
-38.29%
1년 성능:
-52.21%
1일 변동 폭
Value
$1.07
$1.1278
1주일 범위
Value
$1.06
$1.17
52주 변동 폭
Value
$0.70
$2.75

Therapeuticsmd Inc Stock (TXMD) Company Profile

Name
명칭
Therapeuticsmd Inc
Name
부문
Healthcare (1173)
Name
산업
Drug Manufacturers - Specialty & Generic (1)
Name
전화
561-961-1900
Name
주소
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Name
직원
1
Name
트위터
@TherapeuticsMD
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
TXMD's Discussions on Twitter

TXMD을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
TXMD
Therapeuticsmd Inc
 1.08 12.46M 996.00K -6.09M -9.76M -0.53
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
 170.90 77.10B 9.15B 2.43B 2.31B 5.32
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
 9.47 42.82B 14.26B 1.55B 0 0.3383
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
 13.39 42.45B 30.27B 1.93B 3.45B 0.6044
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
 17.73 20.09B 16.77B -959.00M 1.37B -0.85
Drug Manufacturers - Specialty & Generic icon
NBIX
Neurocrine Biosciences Inc
 151.82 15.37B 2.24B 385.90M 440.10M 3.73

Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2020-08-07 다운그레이드 Jefferies Hold → Underperform
2020-05-19 다운그레이드 JP Morgan Overweight → Neutral
2019-12-02 개시 Guggenheim Buy
2019-10-17 개시 H.C. Wainwright Buy
2019-04-30 재개 Noble Capital Markets Outperform
2018-06-15 개시 JP Morgan Overweight
2017-09-08 개시 Morgan Stanley Equal-Weight
2017-07-11 업그레이드 Oppenheimer Perform → Outperform
2017-05-09 다운그레이드 Oppenheimer Outperform → Perform
2016-11-22 재개 Jefferies Buy
2016-11-22 개시 Oppenheimer Outperform
2016-11-07 재개 Guggenheim Buy
2016-04-04 개시 Goldman Buy
2015-12-08 재확인 Jefferies Buy
2015-12-08 재확인 Stifel Buy
2015-09-21 재확인 Jefferies Buy
2015-06-09 개시 Guggenheim Buy
2014-07-08 개시 FBR Capital Outperform
2014-04-17 재확인 Noble Financial Buy
2014-01-28 재확인 Noble Financial Buy
모두보기

Therapeuticsmd Inc 주식(TXMD)의 최신 뉴스

pulisher
Jan 28, 2025

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Jan 28, 2025
pulisher
Jan 24, 2025

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Jan 24, 2025
pulisher
Jan 16, 2025

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Jan 16, 2025
pulisher
Jan 14, 2025

StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD) - Defense World

Jan 14, 2025
pulisher
Jan 13, 2025

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

Jan 13, 2025
pulisher
Jan 10, 2025

TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch

Jan 10, 2025
pulisher
Jan 08, 2025

TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Jan 08, 2025
pulisher
Jan 08, 2025

TherapeuticsMD (NASDAQ:TXMD) Coverage Initiated at StockNews.com - Defense World

Jan 08, 2025
pulisher
Jan 03, 2025

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch

Jan 03, 2025
pulisher
Jan 03, 2025

3 Promising US Penny Stocks With Over $9M Market Cap - Simply Wall St

Jan 03, 2025
pulisher
Jan 02, 2025

StockNews.com Initiates Coverage on TherapeuticsMD (NASDAQ:TXMD) - Defense World

Jan 02, 2025
pulisher
Dec 30, 2024

TXMD stock touches 52-week low at $1.04 amid market challenges - Investing.com Nigeria

Dec 30, 2024
pulisher
Dec 30, 2024

TXMD stock touches 52-week low at $1.04 amid market challenges By Investing.com - Investing.com South Africa

Dec 30, 2024
pulisher
Dec 27, 2024

TherapeuticsMD Inc. stock remains steady Friday, still outperforms market - MarketWatch

Dec 27, 2024
pulisher
Dec 21, 2024

TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com - Defense World

Dec 21, 2024
pulisher
Dec 20, 2024

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Dec 20, 2024
pulisher
Dec 17, 2024

TXMD stock touches 52-week low at $1.13 amid market challenges By Investing.com - Investing.com South Africa

Dec 17, 2024
pulisher
Dec 17, 2024

TXMD stock touches 52-week low at $1.13 amid market challenges - Investing.com India

Dec 17, 2024
pulisher
Dec 12, 2024

TherapeuticsMD Inc. stock remains steady Thursday, still outperforms market - MarketWatch

Dec 12, 2024
pulisher
Dec 06, 2024

TherapeuticsMD holds annual meeting, elects directors - Investing.com

Dec 06, 2024
pulisher
Dec 06, 2024

TherapeuticsMD holds annual meeting, elects directors By Investing.com - Investing.com Canada

Dec 06, 2024
pulisher
Dec 05, 2024

TherapeuticsMD (STU:29TA) 3-Year FCF Growth Rate : 57.70% (As of Sep. 2024) - GuruFocus.com

Dec 05, 2024

Therapeuticsmd Inc (TXMD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Therapeuticsmd Inc 주식 (TXMD) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Collins Cooper C.
Director
Aug 21 '24
Buy
1.70
1,200
2,039
47,922

TXMD과 유사한 종목

drug_manufacturers_specialty_generic ALKS
$31.53
price down icon 1.19%
drug_manufacturers_specialty_generic ELAN
$12.03
price down icon 3.53%
drug_manufacturers_specialty_generic LNTH
$92.51
price down icon 0.30%
drug_manufacturers_specialty_generic VTRS
$11.28
price down icon 1.23%
drug_manufacturers_specialty_generic ITCI
$127.08
price up icon 0.06%
drug_manufacturers_specialty_generic NBIX
$151.82
price down icon 0.96%
야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개
자본화:     |  볼륨(24시간):